Efficacy of 12 Weeks Versus 24 Weeks Treatment of Directly Acting Antiviral Therapy in Patients With Hepatitis C Related Chronic Liver Disease

NCT07702396 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

192

Enrollment

OTHER

Sponsor class

Conditions

Heptatitis C

Interventions

OTHER: 12 weeks Sofosbuvir 400 mg once daily, Daclatasvir 60 mg once daily, and Ribavirin 400 mg twice daily

Sponsor

Indus Hospital and Health Network